Piers Dawes

My research is widely cited in national and international guidelines & policy, including the 2016 US National Academies of Sciences Engineering and Medicine report ‘Hearing Health Care for Adults: Priorities for Improving Access and Affordability’; the UK National Institute for Health and Care Excellence (NICE) guidance ‘Hearing Loss in adults: Assessment and management’; the Australian Parliamentary report on hearing loss ‘Still waiting to be heard’; the 2020 Lancet report on dementia prevention and care; and the WHO guidelines ‘Risk reduction of cognitive decline and dementia’. My research has global impact, including authorship of the first international guidelines on assessment and management of hearing/vision impairment for people with dementia and development and publication of alternative versions of the Montreal Cognitive Assessment (internationally the most used cognitive screening test) for people with hearing or vision impairment.

My work on developing European networks for consumer and community involvement (CCI) of older adults with lived experience of hearing/vision and cognitive difficulties to inform multi-centre health research was identified for a keynote presentation to open the 2018 INVOLVE (the UK NIHR CCI organization) CCI conference and is cited as a gold standard example by the European INTERDEM initiative to guide integrated biomedical and psychosocial dementia research.

I am on the editorial board of Ear and Hearing, the International Journal of Audiology, and the Journal of Audiology & Otology. I am a peer reviewer for >30 journals, as well as the NHMRC, the NIHR, the ESRC, the MRC and the RNID. I represent the University of Queensland on the Hearing Health Sector Alliance and I am the chair of the Hearing Health Sector Alliance's aged care working group. I am on the Research Committee of the Deafness Foundation.